Citadel Advisors - DICE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,721,116
-62.2%
58,569
-76.7%
0.00%0.0%
Q1 2023$7,205,246
+16.4%
251,492
+26.8%
0.00%0.0%
Q4 2022$6,188,676
-69.1%
198,355
-79.9%
0.00%
-80.0%
Q3 2022$20,057,000
+39.9%
988,966
+7.0%
0.01%
+25.0%
Q2 2022$14,338,000
+557.4%
923,849
+710.5%
0.00%
Q1 2022$2,181,000
-21.2%
113,985
+4.2%
0.00%
-100.0%
Q4 2021$2,768,000109,3560.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders